Orphanse Healthcare
Orphanse Healthcare is a company based in Lyon, France, specializing in the development of pharmaceutical products administered via transmucosal routes. Their main activity is R&D, focusing on developing alternative pharmaceutical solutions using their patented BPM® technology. They aim to create fast-acting, safe, simple, and patient-acceptable medications with positive economic impact, particularly targeting pediatric and dysphagic populations. The company also offers strategic and operational consulting services for biotech and pharmaceutical SMEs.
Industries
Nr. of Employees
small (1-50)
Orphanse Healthcare
Products
ORH-01 (transmucosal product candidate)
Product candidate developed for transmucosal administration that completed a proof-of-concept study in 16 healthy volunteers; preparation for a pivotal study is ongoing.
Pre-formulation product programs (two projects)
Two additional transmucosal product development projects currently in pre-formulation stages.
ORH-01 (transmucosal product candidate)
Product candidate developed for transmucosal administration that completed a proof-of-concept study in 16 healthy volunteers; preparation for a pivotal study is ongoing.
Pre-formulation product programs (two projects)
Two additional transmucosal product development projects currently in pre-formulation stages.
Services
Advisory and implementation services including development strategy, business development, project management, and support for preclinical activities (CMC and in vivo studies).
Advisory and implementation services including development strategy, business development, project management, and support for preclinical activities (CMC and in vivo studies).
Expertise Areas
- Transmucosal / buccal drug development
- Formulation and pre-formulation
- CMC development
- Preclinical in vivo studies (pharmacology and toxicology)
Key Technologies
- Transmucosal / oromucosal delivery
- Buccal drug delivery systems
- Platform-based mucosal delivery
- Formulation science and pre-formulation
News & Updates
A study demonstrating the rapid analgesic effect of buccal acetaminophen.
A clinical trial evaluating a new buccal formulation of acetaminophen for acute pain.
A study demonstrating the rapid analgesic effect of buccal acetaminophen.
A clinical trial evaluating a new buccal formulation of acetaminophen for acute pain.